EP2300 Compounds: Focusing on the Antiatherosclerotic Properties of Squalene Synthase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|27|3167-3178

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.27, 2009-09, pp. : 3167-3178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Squalene Synthase Inhibitors: An Update on the Search for New Antihyperlipidemic and Antiatherosclerotic Agents

By  

Current Medicinal Chemistry, Vol. 18, Iss. 29, 2011-10 ,pp. : 4418-4439

Bentham Science Publishers

Access to resources Recommend Favorite

Squalene synthase inhibitors 1998

By Rosenberg S.H.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-05 ,pp. : 521-530

Informa Healthcare

Access to resources Recommend Favorite

Emerging lipid-lowering drugs: squalene synthase inhibitors

By Elsayed Raghda K   Evans Jeffery D  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 309-322

Informa Healthcare

Access to resources Recommend Favorite

Squalene Synthase Inhibitors: Clinical Pharmacology and Cholesterol-Lowering Potential

By Charlton-Menys Valentine   Durrington Paul N.  

Drugs, Vol. 67, Iss. 1, 2007-01 ,pp. : 11-16

Adis International

Access to resources Recommend Favorite

Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds

By Tanous David   Hime Neil   Stocker Roland  

Redox Report, Vol. 13, Iss. 2, 2008-04 ,pp. : 48-59

Maney Publishing

Access to resources Recommend Favorite